Skip to main content
. 2018 Feb 7;15(4):5093–5097. doi: 10.3892/ol.2018.7991

Table I.

Association between CTLA-4 expression and clinicopathological characteristics.

Tumor CTLA-4 Interstitial CTLA-4


Clinicopathological characteristics n (+) (−) P-value (+) (−) P-value
Age (years) 0.099 0.845
  <35 8 6 2 5 3
  ≥35 94 36 58 49 45
Menopausal status 0.868 0.560
  Premenopausal 52 21 31 29 23
  Postmenopausal 50 21 29 25 25
Histological grade 0.422 0.148
  I 16 6 10 11 5
  II 58 27 31 32 26
  III 28 9 19 11 17
Tumor size (cm) 0.636 0.243
  ≤2 49 19 30 23 26
  >2 53 23 30 31 22
Lymph node 0.332 0.161
  Negative 52 19 33 24 28
  Positive 50 23 27 30 20
Tumor stage 0.298 0.114
  I 29 10 19 11 18
  II 47 18 29 26 21
  III 26 14 12 17 9
Ki-67 0.884 0.376
  <14 9 3 6 3 6
  ≥14 93 39 54 51 42

CTLA-4, cytotoxic T lymphocyte-associated antigen 4.